The AE pattern differs from those observed in previous clinical trials for other mTOR inhibitors, in which the most common AEs were stomatitis, anorexia, anemia, dyspnea, and pneumonitis [10, 29]. The gene discussed is MTOR; the disease is anemia (phenotype).